“I can appreciate that there may be occasional patients in whom one has a strong sense that better information about central pressures and so forth will aid decision-making and care,” Dr. Angus said. “However, if the rate is genuinely rising, then I would like to see proponents for its use articulate ‘how’ it should be used and, ideally, ‘prove’ the benefit in a randomized controlled trial.”
The authors reported no funding. Dr. Fonarow reports receiving research support from the Agency for Healthcare Research and Quality and the National Institutes of Health and serving as a consultant for Amgen, Bayer, Gambro, Novartis, and Medtronic.
Pages: 1 2 | Single Page
Loading ...
No Responses to “Pulmonary Artery Catheterization Increased Despite Negative Findings”